Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Helen Vålerhaugen"'
Autor:
Marta Brunetti, Kristin Andersen, Signe Spetalen, Andrea Lenartova, Liv Toril Nygård Osnes, Helen Vålerhaugen, Sverre Heim, Francesca Micci
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionAlterations of the NUP214 gene (9q34) are recurrent in acute leukemias. Rearrangements of chromosomal band 9q34 targeting this locus can be karyotypically distinct, for example t(6;9)(p22;q34)/DEK::NUP214, or cryptic, in which case no vis
Externí odkaz:
https://doaj.org/article/6e54dab0855646e29369ccaf4222b21f
Publikováno v:
Bioingeniøren, Vol 50, Iss 1, Pp 14-20 (2016)
Background: Cell-free DNA (cfDNA) was first reported in 1948 at variable levels in blood samples, but more than two decades passed until it was discovered that it also could represent DNA from tumors. The amount cfDNA is often very low and in additio
Externí odkaz:
https://doaj.org/article/823e6d7937124579ab5d3f05c960cf52
Autor:
A. Lilleorg, Nina Toft, Jonas Abrahamsson, Mats Ehinger, Ulrika Norén-Nyström, Hanne Vibeke Marquart, Anne Tierens, M. Marincevic, Kaie Pruunsild, Vesa Juvonen, Hans O. Madsen, Susanne Rosthøj, Liv T. N. Osnes, Anna Porwit, Mervi Taskinen, Kim Vettenranta, Sanna Siitonen, Bendik Lund, Helen Vålerhaugen, Signe Modvig, Magnus Hultdin, Kjeld Schmiegelow, Olafur G. Jonsson, Helene Hallböök, Mindaugas Stoškus, Goda Vaitkeviciene, Reda Matuzeviciene
Publikováno v:
Leukemia
Leukemia, London : Springer Nature, 2021, vol. 35, iss. 7, p. 1894-1906
Modvig, S, Hallböök, H, Madsen, H O, Siitonen, S, Rosthøj, S, Tierens, A, Juvonen, V, Osnes, L T N, Vålerhaugen, H, Hultdin, M, Matuzeviciene, R, Stoskus, M, Marincevic, M, Lilleorg, A, Ehinger, M, Norén-Nystrøm, U, Toft, N, Taskinen, M, Jónsson, O G, Pruunsild, K, Vaitkeviciene, G, Vettenranta, K, Lund, B, Abrahamsson, J, Porwit, A, Schmiegelow, K & Marquart, H V 2021, ' Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting ', Leukemia, vol. 35, pp. 1894–1906 . https://doi.org/10.1038/s41375-020-01100-5
Leukemia, London : Springer Nature, 2021, vol. 35, iss. 7, p. 1894-1906
Modvig, S, Hallböök, H, Madsen, H O, Siitonen, S, Rosthøj, S, Tierens, A, Juvonen, V, Osnes, L T N, Vålerhaugen, H, Hultdin, M, Matuzeviciene, R, Stoskus, M, Marincevic, M, Lilleorg, A, Ehinger, M, Norén-Nystrøm, U, Toft, N, Taskinen, M, Jónsson, O G, Pruunsild, K, Vaitkeviciene, G, Vettenranta, K, Lund, B, Abrahamsson, J, Porwit, A, Schmiegelow, K & Marquart, H V 2021, ' Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting ', Leukemia, vol. 35, pp. 1894–1906 . https://doi.org/10.1038/s41375-020-01100-5
PCR of TCR/Ig gene rearrangements is considered the method of choice for minimal residual disease (MRD) quantification in BCP-ALL, but flow cytometry analysis of leukemia-associated immunophenotypes (FCM-MRD) is faster and biologically more informati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::038775521046b5a44dd410b0c26e4f28
http://europepmc.org/articles/PMC8257490
http://europepmc.org/articles/PMC8257490
Autor:
Jonas Abrahamsson, Hans Beier Ommen, Helen Vålerhaugen, Kirsi Jahnukainen, Birgitte Lausen, Linda Fogelstrand, Sofie Johansson Alm, Christiane Walter, Bernward Zeller, Veli Kairisto, Nils von Neuhoff, Dirk Reinhardt, Henrik Hasle, Charlotte Guldborg Nyvold, Kristian Løvvik Juul-Dam
Publikováno v:
Juul-Dam, K L, Ommen, H B, Nyvold, C G, Walter, C, Vålerhaugen, H, Kairisto, V, Abrahamsson, J, Alm, S J, Jahnukainen, K, Lausen, B, Reinhardt, D, Zeller, B, von Neuhoff, N, Fogelstrand, L & Hasle, H 2020, ' Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia ', British Journal of Haematology, vol. 190, no. 2, pp. 198-208 . https://doi.org/10.1111/bjh.16560
Løvvik Juul-Dam, K, Ommen, H B, Nyvold, C G, Walter, C, Vålerhaugen, H, Kairisto, V, Abrahamsson, J, Johansson Alm, S, Jahnukainen, K, Lausen, B, Reinhardt, D, Zeller, B, Von Neuhoff, N, Fogelstrand, L & Hasle, H 2018, ' Measurable Residual Disease Assessment By qPCR in Peripheral Blood Is an Informative Tool for Disease Surveillance in Childhood Acute Myeloid Leukemia ', American Society of Hematology: 60th Annual Meeting (ASH), San Diego, USA, 29/11/2018-04/12/2018 . < https://ash.confex.com/ash/2018/webprogram/Paper119642.html >
Løvvik Juul-Dam, K, Ommen, H B, Nyvold, C G, Walter, C, Vålerhaugen, H, Kairisto, V, Abrahamsson, J, Johansson Alm, S, Jahnukainen, K, Lausen, B, Reinhardt, D, Zeller, B, Von Neuhoff, N, Fogelstrand, L & Hasle, H 2018, ' Measurable Residual Disease Assessment By qPCR in Peripheral Blood Is an Informative Tool for Disease Surveillance in Childhood Acute Myeloid Leukemia ', Blood, vol. 132, no. Suppl. 1 . https://doi.org/10.1182/blood-2018-99-119642
Løvvik Juul-Dam, K, Ommen, H B, Nyvold, C G, Walter, C, Vålerhaugen, H, Kairisto, V, Abrahamsson, J, Johansson Alm, S, Jahnukainen, K, Lausen, B, Reinhardt, D, Zeller, B, Von Neuhoff, N, Fogelstrand, L & Hasle, H 2018, ' Measurable Residual Disease Assessment By qPCR in Peripheral Blood Is an Informative Tool for Disease Surveillance in Childhood Acute Myeloid Leukemia ', American Society of Hematology: 60th Annual Meeting (ASH), San Diego, USA, 29/11/2018-04/12/2018 . < https://ash.confex.com/ash/2018/webprogram/Paper119642.html >
Løvvik Juul-Dam, K, Ommen, H B, Nyvold, C G, Walter, C, Vålerhaugen, H, Kairisto, V, Abrahamsson, J, Johansson Alm, S, Jahnukainen, K, Lausen, B, Reinhardt, D, Zeller, B, Von Neuhoff, N, Fogelstrand, L & Hasle, H 2018, ' Measurable Residual Disease Assessment By qPCR in Peripheral Blood Is an Informative Tool for Disease Surveillance in Childhood Acute Myeloid Leukemia ', Blood, vol. 132, no. Suppl. 1 . https://doi.org/10.1182/blood-2018-99-119642
Background: Relapse remains a serious event and main obstacle to permanent cure in childhood acute myeloid leukemia (AML). Reduction of measurable/minimal residual disease (MRD) assessed by real-time quantitative PCR (qPCR) during therapy is predicti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::353c0fd987a10286297c8b440ff07aca
https://pubmed.ncbi.nlm.nih.gov/32191348
https://pubmed.ncbi.nlm.nih.gov/32191348
Autor:
Magnus Hultdin, Signe Modvig, Kjeld Schmiegelow, Kim Vettenranta, Nina Toft, Olafur G. Jonsson, Bendik Lund, Sanna Siitonen, Susanne Rosthøj, Reda Matuzeviciene, Ingrid Thörn, Anne Tierens, Helen Vålerhaugen, Vesa Juvonen, M. Marincevic, Jonas Abrahamsson, Hanne Vibeke Marquart, Liv T. N. Osnes, A. Lilleorg, Kaie Pruunsild, Mindaugas Stoškus, Hans O. Madsen, Goda Vaitkeviciene, Linda Fogelstrand
Publikováno v:
Modvig, S, Madsen, H O, Siitonen, S M, Rosthøj, S, Tierens, A, Juvonen, V, Osnes, L T N, Vålerhaugen, H, Hultdin, M, Thörn, I, Matuzeviciene, R, Stoskus, M, Marincevic, M, Fogelstrand, L, Lilleorg, A, Toft, N, Jónsson, O G, Pruunsild, K, Vaitkeviciene, G, Vettenranta, K, Lund, B, Abrahamsson, J, Schmiegelow, K & Marquart, H V 2019, ' Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia ', Leukemia, vol. 33, pp. 1324–1336 . https://doi.org/10.1038/s41375-018-0307-6
Minimal residual disease (MRD) measured by PCR of clonal IgH/TCR rearrangements predicts relapse in T-cell acute lymphoblastic leukemia (T-ALL) and serves as risk stratification tool. Since 10% of patients have no suitable PCR-marker, we evaluated fl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93bdf3425cc0f5e3367984ece9271438
https://curis.ku.dk/portal/da/publications/minimal-residual-disease-quantification-by-flow-cytometry-provides-reliable-risk-stratification-in-tcell-acute-lymphoblastic-leukemia(580493df-ad8a-4b10-8482-c2f42fb29f1c).html
https://curis.ku.dk/portal/da/publications/minimal-residual-disease-quantification-by-flow-cytometry-provides-reliable-risk-stratification-in-tcell-acute-lymphoblastic-leukemia(580493df-ad8a-4b10-8482-c2f42fb29f1c).html
Autor:
Tomasz Sacha, Spencer Hermanson, Helen Vålerhaugen, Israel Bendit, Smadar Avigad, Carmen Chillón, Shalini C. Reshmi, Gareth Gerrard, Sandra Markovic, Martin C. Mueller, Gianni Cazzaniga, Hubert Serve, J. J. M. Van Dongen, Katarzyna Borg, Tomáš Jurček, Christa Homburg, Oliver G. Ottmann, Veli Kairisto, Fabrizio Pane, Jean-Michel Cayuela, T Touloumenidou, Beat W. Schäfer, Thoralf Lange, Heike Pfeifer, Loredana Elia, Eva Herrmann, Thomas Lion, Christine Damm-Welk, Susanna Akiki, Sandrine Hayette, Orietta Spinelli, Hélène Cavé, Giovanni Martinelli, Peter Vandenberghe, Susanne Schnittger, A. Juh, Lena Rai, Jan Zuna, Vincent H.J. van der Velden
Publikováno v:
Leukemia. 34:1970-1970
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::083de824683e1a5946fc00774abf11f6
https://doi.org/10.1038/s41375-020-0707-2
https://doi.org/10.1038/s41375-020-0707-2